[HTML][HTML] Case definition of chronic pulmonary aspergillosis in resource-constrained settings
DW Denning, ID Page, J Chakaya… - Emerging infectious …, 2018 - ncbi.nlm.nih.gov
Chronic pulmonary aspergillosis (CPA) is a recognized complication of pulmonary
tuberculosis (TB). In 2015, the World Health Organization reported 2.2 million new cases of …
tuberculosis (TB). In 2015, the World Health Organization reported 2.2 million new cases of …
Chronic pulmonary aspergillosis update: A year in review
A Barac, C Kosmidis, A Alastruey-Izquierdo… - Medical …, 2019 - academic.oup.com
Chronic pulmonary aspergillosis (CPA) is an uncommon, slowly destructive pulmonary
disease characterized by progressive cavitation, fibrosis, and pleural thickening. CPA is …
disease characterized by progressive cavitation, fibrosis, and pleural thickening. CPA is …
Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda
M Namusobya, F Bongomin, J Mukisa, WK Olwit… - Mycoses, 2022 - Wiley Online Library
Background The occurrence of chronic pulmonary aspergillosis (CPA) among drug sensitive
pulmonary tuberculosis (PTB) patients on optimal therapy with persistent symptoms was …
pulmonary tuberculosis (PTB) patients on optimal therapy with persistent symptoms was …
[HTML][HTML] Chronic pulmonary aspergillosis—where are we? And where are we going?
GE Hayes, L Novak-Frazer - Journal of Fungi, 2016 - mdpi.com
Chronic pulmonary aspergillosis (CPA) is estimated to affect 3 million people worldwide
making it an under recognised, but significant health problem across the globe, conferring …
making it an under recognised, but significant health problem across the globe, conferring …
[HTML][HTML] Chronic pulmonary aspergillosis: notes for a clinician in a resource-limited setting where there is no mycologist
Chronic pulmonary aspergillosis (CPA) is a spectrum of several progressive disease
manifestations caused by Aspergillus species in patients with underlying structural lung …
manifestations caused by Aspergillus species in patients with underlying structural lung …
A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention
C Godet, A Alastruey-Izquierdo, H Flick… - Journal of …, 2018 - academic.oup.com
Chronic pulmonary aspergillosis (CPA) is a severe fungal infection with a high morbidity and
mortality, and is usually seen in immunocompetent patients with respiratory disorders …
mortality, and is usually seen in immunocompetent patients with respiratory disorders …
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis
T Maitre, J Cottenet, C Godet, A Roussot… - European …, 2021 - Eur Respiratory Soc
Chronic pulmonary aspergillosis (CPA) is an emerging disease in patients with common
chronic pulmonary diseases (CPDs). While its prevalence is linked to tuberculosis (TB) in …
chronic pulmonary diseases (CPDs). While its prevalence is linked to tuberculosis (TB) in …
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities
BACKGROUND: Pulmonary TB (PTB) and chronic pulmonary aspergillosis (CPA) are both
progressive and debilitating parenchymal lung diseases with overlapping risk factors …
progressive and debilitating parenchymal lung diseases with overlapping risk factors …
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
DW Denning, J Cadranel… - European …, 2016 - Eur Respiratory Soc
Chronic pulmonary aspergillosis (CPA) is an uncommon and problematic pulmonary
disease, complicating many other respiratory disorders, thought to affect∼ 240 000 people …
disease, complicating many other respiratory disorders, thought to affect∼ 240 000 people …
[HTML][HTML] Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation
ID Page, R Byanyima, S Hosmane… - European …, 2019 - Eur Respiratory Soc
Chronic pulmonary aspergillosis (CPA) complicates treated pulmonary tuberculosis (TB),
with high 5-year mortality. We measured CPA prevalence in this group. 398 Ugandans with …
with high 5-year mortality. We measured CPA prevalence in this group. 398 Ugandans with …